Enzyme News and Research

RSS

USF Health researchers develop new reporter mouse strain for identifying P2X2-expressing cells

Despite frequent news announcing "medical breakthroughs," advancements in biomedical and clinical science typically happen incrementally.

7 Aug 2020

Large-scale analysis of Alport syndrome reveals the effectiveness of existing treatments

A large-scale analysis of the clinical characteristics of Alport syndrome in Japanese patients has revealed that the effectiveness of existing treatment with ACE inhibitors and/or angiotensin receptor blockers (RAS inhibitors) varies depending on the type of mutation in the syndrome's causal gene (COL4A5).

7 Aug 2020

Fujirebio announces launch of clinical testing for new SARS-CoV-2 Antigen assay

Fujirebio Diagnostics, Inc., a consolidated subsidiary of H.U. Group Holdings, Inc, announced today the initiation of clinical testing needed for the submission of its new SARS-CoV-2 Antigen assay for EUA (Emergency Use Authorization) from the U.S. Food and Drug Administration.

6 Aug 2020

UCI researchers develop novel molecule for COVID-19 treatment

When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus.

6 Aug 2020

Unique molecular mechanics can pave way for potential treatments for infections

Unique molecular mechanics allowing parasites to thrive in the guts of one billion people open the door to new treatments that are safe for the host.

6 Aug 2020

SARS-CoV-2 may not be targeting taste bud cells

An intriguing early symptom among some COVID-19 patients is the loss of the sense of smell and/or taste, which has led to the suspicion that the virus that causes the illness, SARS-CoV-2, could be targeting taste buds.

5 Aug 2020

A SARS-CoV-2 assay using plant proteins

Researchers in South Africa have developed a serological assay that readily detects antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using recombinant viral proteins produced in plants.

5 Aug 2020

Evidence for antibody longevity in COVID-19 patients

A study led by researchers at the University of Toronto, Canada, has found evidence that immunoglobulin G (IgG) antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are sustained for at least three months.

5 Aug 2020

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

New COVID-19 test evaluates herd immunity and vaccine efficacy with high accuracy.

5 Aug 2020

Existing drug used to treat alcoholism is potentially effective against COVID-19

A team of chemists from HSE University and the Zelinsky Institute of Organic Chemistry used molecular modelling to find out that two medications that have been known for a long time can be used to fight SARS-CoV-2.

5 Aug 2020

Discovery of enzyme could provide new route for treating Huntington's disease

Scientists at EPFL's Brain Mind Institute have identified an enzyme that can play a central role in developing a new route of treatment for Huntington's Disease.

5 Aug 2020

Study provides comprehensive update on ACE2 enzyme with key role in SARS-CoV-2 infection

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

5 Aug 2020

GADL1 enzyme may be linked to athletic performances, shows study

Carnosine and its precursor beta-alanine increases muscle strength, and have recently become extremely popular as dietary supplements in competitive sports.

5 Aug 2020

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

A laboratory test that has now been developed by a study group from MedUni Vienna is able to determine whether COVID-19 patients develop protective antibodies after having the disease.

5 Aug 2020

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

In a new study published on the preprint server bioRxiv researchers characterized the crystal structure of the antibody-SARS-CoV-2 RBD complex in an attempt to find the epitope and the mechanism that enables cross-neutralization.

5 Aug 2020

Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients

Neutrolis, a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cells in the body, today announced the development of NTR-441, a first-in-class DNASE1L3 enzyme analog that has the potential to rapidly and systemically clear neutrophil extracellular traps for severe cases of COVID-19.

5 Aug 2020

Enzyme could play key role in treating cancer, autoimmune diseases in the airway

Findings from a research study, led by scientists at Henry Ford, published in the latest issue of Nature Communications suggest an enzyme could play an important role in the treatment of cancer and autoimmune diseases in the airway.

5 Aug 2020

Study shows link between selenium-deficient diet and paracetamol toxicity

A lack of the mineral selenium in the diet puts people at risk of paracetamol overdose, even when the painkiller is taken at levels claimed to be safe on the packaging, according to collaborative research emerging from the University of Bath and Southwest University in China.

5 Aug 2020

De novo protein decoys that block SARS-CoV-2

Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.

5 Aug 2020

Biomedical engineers create artificial organelles to control biological function in cells

Biomedical engineers at Duke University have demonstrated a method for controlling the phase separation of an emerging class of proteins to create artificial membrane-less organelles within human cells.

4 Aug 2020

Enzyme News and Research

USF Health researchers develop new reporter mouse strain for identifying P2X2-expressing cells

Large-scale analysis of Alport syndrome reveals the effectiveness of existing treatments

Fujirebio announces launch of clinical testing for new SARS-CoV-2 Antigen assay

UCI researchers develop novel molecule for COVID-19 treatment

Unique molecular mechanics can pave way for potential treatments for infections

SARS-CoV-2 may not be targeting taste bud cells

A SARS-CoV-2 assay using plant proteins

Evidence for antibody longevity in COVID-19 patients

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

Existing drug used to treat alcoholism is potentially effective against COVID-19

Discovery of enzyme could provide new route for treating Huntington's disease

Study provides comprehensive update on ACE2 enzyme with key role in SARS-CoV-2 infection

GADL1 enzyme may be linked to athletic performances, shows study

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

Neutrolis announces development of first-in-class therapy to target NETs in COVID-19 patients

Enzyme could play key role in treating cancer, autoimmune diseases in the airway

Study shows link between selenium-deficient diet and paracetamol toxicity

De novo protein decoys that block SARS-CoV-2

Biomedical engineers create artificial organelles to control biological function in cells

Biochemistry eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo